Peter D. Siersema
Gastroenterology · 2008–2018
A researcher in the Science corpus: 4 papers; trusts 0 researchers and is trusted by 9 researchers here, as inferred from the citation graph.
Who trusts Peter D. Siersema overall
- J. Luketich
- Edgar P. Simard
- A. Pennathur
- G. De Pergola
- Yuwei Zhang
- R. Siegel
- Elizabeth E. Ward
- F. Bray
Papers from Peter D. Siersema's perspective
Ordered by how strongly the researchers Peter D. Siersema trusts endorse each paper. Same corpus, a different order for every researcher.
- Extended Transthoracic Resection Compared With Limited Transhiatal Resection for Adenocarcinoma of the Mid/Distal Esophagus: Five-Year Survival of a Randomized Clinical Trial (Annals of Surgery)
- GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. (Journal of Clinical Epidemiology)
- Angiogenins: a new class of microbicidal proteins involved in innate immunity (Nature Immunology)
- Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis (Nature Clinical Practice Gastroenterology &Hepatology)
- Inflammatory bowel disease. (The Pediatric clinics of North America)
- Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. (Proceedings of the National Academy of Sciences of the United States of America)
- The Bile Acid Receptor FXR Is a Modulator of Intestinal Innate Immunity1 (Journal of Immunology)
- Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. (Gastroenterology)
- Targeting bile-acid signalling for metabolic diseases (Nature reviews. Drug discovery)
- Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus (Gut)
Their papers
- Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline – Updated October 2017 (2018) — 715 citations
- Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. (2011) — 3,443 citations
- Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease (2011) — 792 citations
- Esophageal cancer. (2008) — 2,554 citations